Glucose Biosensor - Global Market Outlook (2015-2022)

March 2016 | 137 pages | ID: G5F307E4285EN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Glucose Biosensor Market is accounted for $15.3 billion in 2015 and is expected to reach $30.5 billion by 2022 growing at a CAGR of 10.29% from 2015 to 2022. Growing demand for expansion of technologically advanced products and non-invasive products are some of the primary factors favouring the market growth. Furthermore, increasing frequency of diabetes across the globe, need for early diabetes detection and patient awareness levels are some of the drivers fuelling the market growth. However, high cost, reluctance towards the adoption of the new treatment practices and slow rate of commercialization are the restraints limiting the market growth. The recent trends in Glucose Biosensors market are increasing adoption of the POC diagnostic kits and wearable healthcare devices.

Fluorescence segment is expected to capture the largest market share over the forecast period. North America is expected to witness highest growth rate in terms of value and share. High disease burden and the subsequent need to curb associated healthcare expenditure in the U.S. is attributing to the favorable North American market.

Some of the key players in the market include Roche Diagnostics, LifeScan Inc., Abbott Laboratories, Bayer, Medtronic Inc., Pinnacle Medical Solutions Inc., AgaMatrix Inc., Sanofi S.A., BioSense Medical Devices, LLC, Nova Biomedical, Lifesensors, Inc., Animas Corporation, Siemens Healthcare Diagnostics, Inc., F. Hoffman-La Roche and M-Biotech Limited.

End User Covered:

• Hospitals
• Homecare Diagnostics
• Other end users

Type Covered:

• Amprometric Glucose Biosensors
• Fluorescence Glucose Biosensors
• Other types

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• Italy
• UK
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• Rest of Asia Pacific
• Rest of the World
• Middle East
• Brazil
• Argentina
• South Africa
• Egypt

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.7 End user Analysis
3.6 Emerging Markets

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL GLUCOSE BIOSENSOR MARKET, BY END USER

5.1 Introduction
5.2 Hospitals
5.3 Homecare Diagnostics
5.4 Other end users

6 GLOBAL GLUCOSE BIOSENSOR MARKET, BY TYPE

6.1 Introduction
6.2 Amprometric Glucose Biosensors
6.3 Fluorescence Glucose Biosensors
6.4 Other types

7 GLOBAL GLUCOSE BIOSENSOR MARKET, BY GEOGRAPHY

7.1 North America
  7.1.1 US
  7.1.2 Canada
  7.1.3 Mexico
7.2 Europe
  7.2.1 Germany
  7.2.2 France
  7.2.3 Italy
  7.2.4 UK
  7.2.5 Spain
  7.2.7 Rest of Europe
7.3 Asia Pacific
  7.3.1 Japan
  7.3.2 China
  7.3.3 India
  7.3.4 Australia
  7.3.5 New Zealand
  7.3.7 Rest of Asia Pacific
7.4 Rest of the World
  7.4.1 Middle East
  7.4.2 Brazil
  7.4.3 Argentina
  7.4.4 South Africa
  7.4.5 Egypt

8 KEY DEVELOPMENTS

8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 COMPANY PROFILING

9.1 Roche Diagnostics
9.2 LifeScan Inc.
9.3 Abbott Laboratories
9.4 Bayer
9.5 Medtronic Inc.
9.6 Pinnacle Medical Solutions Inc.
9.7 AgaMatrix Inc.
9.9 Sanofi S.A.
9.9 BioSense Medical Devices, LLC
9.10 Nova Biomedical
9.11 Lifesensors, Inc.
9.12 Animas Corporation
9.13 Siemens Healthcare Diagnostics, Inc.
9.14 F. Hoffman-La Roche
9.15 M-Biotech Limited

List Of Tables

LIST OF TABLES

Global Glucose Biosensor Market Outlook, By Region (201-2022) ($MN)
Global Glucose Biosensor Market Outlook, By End User (201-2022) ($MN)
Global Glucose Biosensor Market Outlook, By Hospitals (201-2022) ($MN)
Global Glucose Biosensor Market Outlook, By Homecare Diagnostics (201-2022) ($MN)
Global Glucose Biosensor Market Outlook, By Other End users (201-2022) ($MN)
Global Glucose Biosensor Market Outlook, By Type (201-2022) ($MN)
Global Glucose Biosensor Market Outlook, By Amprometric Glucose Biosensors (201-2022) ($MN)
Global Glucose Biosensor Market Outlook, By Fluorescence Glucose Biosensors (201-2022) ($MN)
Global Glucose Biosensor Market Outlook, By Other Types (CNS) (201-2022) ($MN)
North America Glucose Biosensor Market Outlook, By End User (201-2022) ($MN)
North America Glucose Biosensor Market Outlook, By Hospitals (201-2022) ($MN)
North America Glucose Biosensor Market Outlook, By Homecare Diagnostics (201-2022) ($MN)
North America Glucose Biosensor Market Outlook, By Other End users (201-2022) ($MN)
1North America Glucose Biosensor Market Outlook, By Type (201-2022) ($MN)
North America Glucose Biosensor Market Outlook, By Amprometric Glucose Biosensors (201-2022) ($MN)
North America Glucose Biosensor Market Outlook, By Fluorescence Glucose Biosensors (201-2022) ($MN)
North America Glucose Biosensor Market Outlook, By Other Types (CNS) (201-2022) ($MN)
Europe Glucose Biosensor Market Outlook, By End User (201-2022) ($MN)
Europe Glucose Biosensor Market Outlook, By Hospitals (201-2022) ($MN)
Europe Glucose Biosensor Market Outlook, By Homecare Diagnostics (201-2022) ($MN)
Europe Glucose Biosensor Market Outlook, By OtherEnd users (201-2022) ($MN)
Europe Glucose Biosensor Market Outlook, By Type (201-2022) ($MN)
2Europe Glucose Biosensor Market Outlook, By Amprometric Glucose Biosensors (201-2022) ($MN)
Europe Glucose Biosensor Market Outlook, By Fluorescence Glucose Biosensors (201-2022) ($MN)
Europe Glucose Biosensor Market Outlook, By Other types (CNS) (201-2022) ($MN)
Asia pacific Glucose Biosensor Market Outlook, By End User (201-2022) ($MN)
Asia pacific Glucose Biosensor Market Outlook, By Hospitals (201-2022) ($MN)
Asia pacific Glucose Biosensor Market Outlook, By Homecare Diagnostics (201-2022) ($MN)
Asia pacific Glucose Biosensor Market Outlook, By Other End Users (201-2022) ($MN)
Asia pacific Glucose Biosensor Market Outlook, By Type (201-2022) ($MN)
Asia pacific Glucose Biosensor Market Outlook, By Amprometric Glucose Biosensors (201-2022) ($MN)
3Asia pacific Glucose Biosensor Market Outlook, By Fluorescence Glucose Biosensors (201-2022) ($MN)
Asia pacific Glucose Biosensor Market Outlook, By Other Types (CNS) (201-2022) ($MN)
Rest of the World Glucose Biosensor Market Outlook, By End User (201-2022) ($MN)
Rest of the World Glucose Biosensor Market Outlook, By Hospitals (201-2022) ($MN)
Rest of the World Glucose Biosensor Market Outlook, By Homecare Diagnostics (201-2022) ($MN)
Rest of the World Glucose Biosensor Market Outlook, By Other End Users (201-2022) ($MN)
Rest of the World Glucose Biosensor Market Outlook, By Type (201-2022) ($MN)
Rest of the World Glucose Biosensor Market Outlook, By Amprometric Glucose Biosensors (201-2022) ($MN)
Rest of the World Glucose Biosensor Market Outlook, By Fluorescence Glucose Biosensors (201-2022) ($MN)
Rest of the World Glucose Biosensor Market Outlook, By Other Types (CNS) (201-2022) ($MN)